S&P Futures
4,561.00 +5.00 (+0.11%) Dow Futures
36,077.00 -35.00 (-0.10%) Nasdaq Futures
15,864.75 +49.50 (+0.31%) Russell 2000 Futures
1,848.20 -6.60 (-0.36%) Crude Oil
70.19 +0.81 (+1.17%) Gold
2,049.30 +1.40 (+0.07%)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 0.8480 |
| Open | 0.8221 |
| Bid | 0.7955 x 800 |
| Ask | 0.8120 x 1100 |
| Day's Range | 0.8221 - 0.8600 |
| 52 Week Range | 0.4500 - 1.4400 |
| Volume | |
| Avg. Volume | 127,792 |
| Market Cap | 43.003M |
| Beta (5Y Monthly) | 1.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4700 |
| Earnings Date | Nov 15, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.62 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for EVGN
Related Research
- Evogene Ltd.Analyst Report: Motorola Solutions, Inc.Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm’s revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment and dispatch software. Most of Motorola’s revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.RatingFair ValueEconomic Moat10 months agoMorningstar
ZacksIs Compugen (CGEN) Outperforming Other Medical Stocks This Year?
Here is how Compugen (CGEN) and Evogene (EVGN) have performed compared to their sector so far this year.
PR NewswireLavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products, today announced a distribution agreement exclusive to independent retail with WinField United Canada for its bio-inoculant seed treatment Yalos™. This partnership aims to support Lavie Bio's 2024 sales growth strategy in Canada, with a focus on key agricultural regions, including Saskatchewa
ZacksBears are Losing Control Over Evogene (EVGN), Here's Why It's a 'Buy' Now
After losing some value lately, a hammer chart pattern has been formed for Evogene (EVGN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
